Maternal Vitamin D, Folate, and Polyunsaturated Fatty Acid Status and Bacterial Vaginosis during Pregnancy
Table 2
Crude and adjusted odds for bacterial vaginosis during pregnancy according to maternal characteristics.
Characteristic
Bacterial vaginosis ()
No bacterial vaginosis ()
cOR (95% CI)
aOR (95% CI)*
Black race (%)
8 (57.1%)
72 (49.3%)
1.37 (0.45, 4.15)
1.17 (0.36, 3.76)
Teenager (%)
4 (28.6%)
19 (13.0%)
2.67 (0.76, 9.39)
2.27 (0.53, 9.79)
Smoker (%)
6 (42.9%)
31 (21.2%)
2.78 (0.92, 8.61)
3.16 (1.08, 10.21)
Obese (%)
4 (30.8%)
40 (27.8%)
1.16 (0.34, 4.01)
1.33 (0.36, 4.92)
Delivery <37 weeks (%)
10 (71.4%)
70 (47.9%)
2.71 (0.87, 9.05)
1.96 (0.64, 7.10)
TennCare** (%)
8 (57.1%)
74 (50.7%)
1.16 (0.78, 3.85)
1.79 (0.31, 10.32)
Folate <5 ug/L—n (%)
3 (21.4%)
4 (4.0%)
6.55 (1.29, 33.13)
7.06 (1.07, 54.05)
25-OH-D <12 ng/mL—n (%)
5 (35.7%)
10 (6.8%)
7.58 (2.13, 27.03)
5.11 (1.19, 21.97)
25-OH-D <20 ng/mL—n (%)
7 (50%)
62 (42.5%)
1.4 (0.5, 4.1)
1.2 (0.39, 3.85)
Omega-6/omega-3 > 15—n (%)
12 (85.7%)
92 (65.2%)
3.19 (0.79, 14.93)
3.98 (0.78, 13.7)
*The multivariate model included race, age, smoking status, body mass index status, gestational age at delivery, and payor source.
**Tennessee’s Medicaid Managed Care Program that provides health insurance coverage for low-income, pregnant women.
